FLT3

Prof. Keith Pratz | ASH 2017 | Gilteritinib & intensive chemotherapy in newly diagnosed FLT3+ AML

L:

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA